Purdue Pharma L.P.

Type: Company
Name: Purdue Pharma L.P. (Purdue Pharma L.P)
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Give Physicians What They Want

0 Flares 0 Flares×Getting the right message to the right person, at the right time is practically a mantra in pharmaceutical marketing. It is no easy task, as marketers will note, but the tools to achieve it are at hand. Multi-channel marketing, with ... [Published PM 360 - 6 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

My Other Life with Peter Justason

0 Flares 0 Flares×PM360 recently spoke to Peter Justason, Director, eMarketing at Purdue Pharma, about his passion for boating.PM360 : Peter, we hear that you own a boat. Tell us about that.In 2010, to celebrate our 25 th wedding anniversary, my wife, ... [Published PM 360 - 6 hours ago]
First reported Jul 10 2014 - Updated 15 hours ago - 1 reports

Pharmacist's theft of $5.6M worth of oxycodone is sure to escalate backlash

Already dealing with a growing backlash from politicians and law enforcement accusing it of recklessly marketing opioids, the pharmaceutical industry now has to face down a report that a hospital pharmacy director for years was walking out with thousands ... [Published FiercePharma - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 1 reports

"Likes" put Zarbee's in FDA crosshairs

Two weeks after its $46-billion bid was shot down, AbbVie has revised its offer in hopes of opening up negotiations with Shire.The drugmaker received a notice from the advertising watchdog over promotion of hep. B treatment Viread in a sponsored link ... [Published Medical Marketing And Media - Jul 09 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Baker '15 Interns with Mundipharma

Georgia Baker '15 is completing an internship for the multinational pharmaceutical company, Mundipharma, in Basel, Switzerland. Baker, a political science major with a minor in law and society, is currently working with the company's in-house lawyer.As ... [Published Hobart and William Smith Colleges - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

OxyContin maker moves ahead with Treyburn manufacturing facility in Durham

Purdue Pharma Manufacturing chose the KBR Building Group to build its new oral solid dosage manufacturing plant in Durham.The 188,000-square-foot facility will be built on a 51-acre site Treyburn Corporate Park in Durham. Production areas will include ... [Published Business First of Buffalo - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 2 reports

Priority Review for Purdue’s anti-abuse hydrocodone

The US FDA has granted Priority Review Designation to Purdue Pharma’s hydrocodone bitartrate tablet which has abuse-deterrent technology.Priority Review is given by the FDA to drugs that could make major improvements to treatment of serious conditions, ... [Published In-Pharmatechnologist - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 3 reports

KBR To Construct Oral Solid Dosage Production Facility For Purdue Pharma Manufacturing L.P. In Durham, N.C.

KBR (NYSE: KBR) announced today that KBR Building Group, a subsidiary within KBR's Services Group, has been awarded a contract by Purdue Pharma Manufacturing L.P. to build a new Oral Solid Dosage manufacturing plant in Durham, N.C. The 188,000-square-foot, ... [Published EPC Engineer - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 3 reports

FDA grants Priority Review designation for Purdue’s hydrocodone bitartrate

Privately held US drugmaker Purdue Pharma has been granted Priority Review designation by the US Food and Drug Administration for its once-daily, single-entity hydrocodone bitartrate tablet.This has been formulated with abuse-deterrent properties that ... [Published Pharma Letter - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 3 reports

Purdue pain drug gets priority status

Share this article: Purdue Pharma announced Tuesday that the Food and Drug Administration has granted Priority Review to its experimental hydrocodone bitartrate tablet. The Connecticut drugmaker expects the FDA will review the daily, extended release ... [Published Medical Marketing And Media - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

FDA Grants Priority Review Designation for Purdue Pharma's Once-Daily Hydrocodone Bitartrate Extended-Release Tablets Formulated with Abuse-Deterrent Properties

/PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) has granted Priority Review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet (HYD).  This investigational pain medication ... [Published CEOWorld Magazine - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 1 reports

Canadian pills allegedly travel long-distance

WASHINGTON – The ongoing availability in Canada of an abuse-prone pharmaceutical may be having a spillover effect far beyond its borders.A form of OxyContin that was banned in the United States last year is still showing up in distant corners of the country, ... [Published Metro Canada - Jul 07 2014]

Quotes

...how the company operates within Switzerland and how the differing regulations affect operations with companies in various countries," says Baker. "This has been very interesting, because I am learning about multiple forms of regulations rather than just one."
...released the 2014 edition of US national drug control strategy, a 102-page document that leads off with a paean from the Man himself touting an "evidence-based plan for real drug policy reform, spanning the spectrum of effective prevention, early intervention, treatment, recovery support, criminal justice, law enforcement, and international cooperation." But this latest agenda, while laudable for moving away from a "war on drugs" mentality and highlighting opiate addiction, goes out of its way to defend...
...If D'Alessandro had downed all the pills that were stolen, "we would be at his funeral rather than his arraignment" prosecutor Ryan Sakacs told the court
Commenting on the priority designation status for its drug application, Mark Timney, president and CEO of Purdue Pharma, said it was "another milestone in our effort to offer patients and health professionals a portfolio of pain medications with abuse-deterrent technology."

More Content

All (153) | News (125) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (1) | Press Releases (1)
sort by: Date | Relevance
My Other Life with Peter Justason [Published PM 360 - 6 hours ago]
Give Physicians What They Want [Published PM 360 - 6 hours ago]
Baker '15 Interns with Mundipharma [Published Hobart and William Smith Colleges - Jul 10 2014]
Obama's New Drug Policy Strategy Is Too Little,... [Published Vice Magazine US - Jul 10 2014]
Pharmacist's theft of $5.6M worth of oxycodone ... [Published FiercePharma - Jul 10 2014]
OxyContin maker moves ahead with Treyburn manuf... [Published Business First of Buffalo - Jul 10 2014]
Priority Review for Purdue’s anti-abuse hydroco... [Published In-Pharmatechnologist - Jul 10 2014]
Purdue Pharma wins Priority Review designation ... [Published Pharmaceutical Commerce - Jul 10 2014]
"Likes" put Zarbee's in FDA crosshairs [Published Medical Marketing And Media - Jul 09 2014]
Update on Tamper-Proof Hydrocodone Products [Published Diabetes Care - Jul 09 2014]
KBR To Construct Oral Solid Dosage Production F... [Published EPC Engineer - Jul 09 2014]
KBR to Construct Oral Solid Dosage Production F... [Published PharmaceuticalProcessing - Jul 09 2014]
KBR to Construct Oral Solid Dosage Production F... [Published Value Investing News - Jul 09 2014]
FDA grants Priority Review designation for Purd... [Published Pharma Letter - Jul 09 2014]
Purdue’s hydrocodone bitartrate tablets granted... [Published Pharmaceutical Technology - Jul 09 2014]
Purdue pain drug gets priority status [Published Medical Marketing And Media - Jul 09 2014]
FDA designates priority review status to Purdue... [Published FirstWord Pharma - Jul 08 2014]
AbbVie Revised Shire Offer; Delta Air, Zogenix ... [Published Ticker - Jul 08 2014]
Purdue Pharma granted priority review designati... [Published Drug Store News - Jul 08 2014]
Why Zogeniz (ZGNX) Stock Is Tumbling Today [Published TheStreet.com - Jul 08 2014]
Why Zogeniz (ZGNX) Stock Is Tumbling Today [Published The Street Latest - Jul 08 2014]
Zogenix Falls On Speculation That Its Drug Will... [Published Bidness Etc - Jul 08 2014]
Tuesday’s Top Health Care Stories: Zogenix, Phi... [Published Motley Fool - Jul 08 2014]
Sector Update: Health-Care Shares Mixed Pre-Mar... [Published Nasdaq - Jul 08 2014]
FDA Grants Priority Review Designation for Purd... [Published CEOWorld Magazine - Jul 08 2014]
FDA Grants Priority Review Designation for Purd... [Published PR Newswire: Policy & Public Interest - Jul 08 2014]
Purdue’s Abuse-Resistant Pill Gets FDA Priority... [Published Bloomberg - Jul 08 2014]
Prescription Opioid Makers Are Big Donors to An... [Published Firedoglake - Jul 08 2014]
OxyContin-like pills discovered smuggled from C... [Published Yahoo! Canada - Jul 07 2014]
Why Is Pot Still Illegal?: The Nation Follows t... [Published San Francisco Chronicle - Jul 07 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA Grants Priority Review Designation for Purd... [Published PR Newswire: Policy & Public Interest - Jul 08 2014]
STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) has granted Priority Review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet (HYD).  This ...
Prescription Opioid Makers Are Big Donors to An... [Published Firedoglake - Jul 08 2014]
On average, opioid prescription rates are noticeably lower in medical marijuana states.  Coincidence? A fascinating article highlights many of the conflicts of interest at the heart of top anti-marijuana legalization groups  in the country : The ...
MS CONTIN (Morphine Sulfate) Tablet, Film Coate... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
Updated Date: Jun 19, 2014 EST ...
Pain Management Therapeutics Market [Published Zunia.org RSS - Jun 19 2014]
Transparency Market Research is Published new Market Report Pain Management Therapeutics Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012-2018," in 2011, the global pain management therapeutics market was valued at USD ...
Pain Management Therapeutics Market growing CAG... [Published Zunia.org RSS - Jun 05 2014]
Transparency Market Research is Published new Market Report Pain Management Therapeutics Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012-2018," in 2011, the global pain management therapeutics market was valued at USD ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Purdue Pharma L.P., a Leading Pharmaceutical Co... [Published Financial Services - Jun 18 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.